4//SEC Filing
Ballance David James 4
Accession 0001169245-20-000100
CIK 0001169245other
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 6:38 PM ET
Size
5.0 KB
Accession
0001169245-20-000100
Insider Transaction Report
Form 4
Ballance David James
VP, Research and Sci. Affairs
Transactions
- Award
Common Stock
2020-11-20$3.00/sh+919$2,757→ 8,519 total
Footnotes (1)
- [F1]These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeother
Related Parties
1- filerCIK 0001755432
Filing Metadata
- Form type
- 4
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 6:38 PM ET
- Size
- 5.0 KB